Dr Greg Cook, the director of access policy and advocacy for Bristol Myers Squibb Australia and New Zealand, spoke with BioPharmaDispatch about the company's submission to the parliamentary inquiry into access to new medicines and medical technologies.
BioPharma
Latest Video
New Stories
-
BMS' Dr Greg Cook on enhancing regulatory and reimbursement processes
March 9, 2021 - - Latest News -
Daily updates on COVID-19 vaccine - 9 March 2021
March 9, 2021 - - COVID-19 -
PAIG companies mark International Women's Day 2021
March 9, 2021 - - Latest News -
Time for intervention on this 'unlawful exercise of power'
March 9, 2021 - - Latest News -
The three women leading emerging Australian biotech
March 8, 2021 - - Australian Biotech -
Bupa's Emily Amos on the need for 'bold' reform
March 8, 2021 - - Other Health -
Noxopharm launches second part of NOXCOVID-1 clinical trial
March 8, 2021 - - Australian Biotech